Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation

Condition:   Asthma
Interventions:   Drug: A006 DPI;   Drug: A006 DPI;   Other: Placebo DPI;   Drug: Proventil® MDI;   Drug: Proventil® MDI
Sponsor:   Amphastar Pharmaceuticals, Inc.
Recruiting – verified August 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.